TREM2 and Alzheimer disease: In addition, genome-wide association studies (GWAS) [7–10] have identified AD risk variants within genes involved in innate immunity (i.e., SPI1, TREM2) [11]), shifting the field to examine a potential causative role of microglia in the pathogenesis of AD.